ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ZSAN

<< 이전 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2017/01/26	06:37	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/01/24	07:18	GlobeNewswire Inc.	Zosano Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/01/06	03:24	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ZSAN	Zosano Pharma Corporation
2017/01/05	22:30	GlobeNewswire Inc.	Zosano Pharma Announces Last Subject Treated in its Migraine Pivotal Trial	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/23	07:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/23	07:00	GlobeNewswire Inc.	Zosano Pharma Announces Sale of Non-Strategic Asset	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/17	03:20	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/10	06:39	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/10	06:35	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/10	06:20	GlobeNewswire Inc.	Zosano Pharma Reports Third Quarter 2016 Financial Results	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/08	22:30	GlobeNewswire Inc.	Zosano Pharma Announces Completion of Enrollment in Pivotal Efficacy Trial for M207 for Acute Migraine	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/05	06:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/05	06:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/05	06:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/05	06:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/11/04	05:15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/10/18	05:58	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/10/15	05:10	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/10/08	05:18	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/26	22:02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/26	19:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/21	05:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/21	05:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/16	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/16	05:32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/10	06:00	GlobeNewswire Inc.	Zosano Announces Inducement Grant for Georgia Erbez, Chief Business Officer	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/10	05:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/10	05:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/10	05:14	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ZSAN	Zosano Pharma Corporation
2016/09/08	21:30	GlobeNewswire Inc.	Zosano Appoints Georgia Erbez as Chief Business Officer	NASDAQ:ZSAN	Zosano Pharma Corporation